INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,148 | -47.4% | 1,400 | 0.0% | 0.00% | – |
| Q4 2022 | $2,184 | -97.4% | 1,400 | -84.6% | 0.00% | -100.0% |
| Q2 2021 | $85,000 | +129.7% | 9,120 | +117.1% | 0.00% | +200.0% |
| Q4 2020 | $37,000 | +8.8% | 4,200 | +42.4% | 0.00% | -50.0% |
| Q3 2020 | $34,000 | +3300.0% | 2,950 | +1240.9% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 220 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 220 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 220 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Triatomic Management LP | 235,000 | $405,000 | 0.23% |
| Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
| Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
| Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
| Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
| Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
| CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
| Keystone Financial Group | 74,058 | $128,000 | 0.03% |
| Virtu Financial LLC | 130,829 | $226,000 | 0.02% |